UCB, Inc. v. Yeda Research and Development Co., Ltd.
UCB, Inc. v. Yeda Research and Development Co., Ltd., 2015-1957
In an declaratory judgment requesting a declaration that plaintiff’s Cimzia brand antibody does not infringe defendant’s patent and that such patent is invalid, the district court’s grant of summary judgment of non-infringement is affirmed where, based on the specification and prosecution history, the monoclonal antibodies claimed in the patent are not infringed by the chimeric or humanized antibodies of the Cimzia product.
- Published 2016/09/08
- United States Federal Circuit